Compare ABOS & RDNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABOS | RDNW |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United States |
| Employees | N/A | 1906 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.9M | 226.9M |
| IPO Year | 2021 | N/A |
| Metric | ABOS | RDNW |
|---|---|---|
| Price | $2.21 | $5.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $8.00 | $6.50 |
| AVG Volume (30 Days) | ★ 685.1K | 163.8K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.01 |
| Revenue Next Year | N/A | $6.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.19 | $2.98 |
| 52 Week High | $3.60 | $8.55 |
| Indicator | ABOS | RDNW |
|---|---|---|
| Relative Strength Index (RSI) | 39.73 | 34.24 |
| Support Level | $2.18 | $5.64 |
| Resistance Level | $2.43 | $6.35 |
| Average True Range (ATR) | 0.21 | 0.43 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 1.59 | 11.73 |
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
RideNow Group Inc operates solely as a powersports dealership group. Its offerings include new and pre-owned vehicles such as motorcycles, all-terrain vehicles (ATVs), side-by-side vehicles (SXS), and personal watercraft (PWC). It also sells parts, apparel, and accessories, and provides financing, insurance, and aftermarket products, along with repair and maintenance services. The majority of the company's revenue is derived from powersports vehicle sales, and the rest from parts, service and accessories/merchandise, and finance and insurance products.